Motives of Dutch persons aged 50 years and older to accept vaccination: a qualitative study.
Identifieur interne : 000090 ( Main/Curation ); précédent : 000089; suivant : 000091Motives of Dutch persons aged 50 years and older to accept vaccination: a qualitative study.
Auteurs : Renske Eilers [Pays-Bas] ; Paul F M. Krabbe [Pays-Bas] ; Hester E. De Melker [Pays-Bas]Source :
- BMC public health [ 1471-2458 ] ; 2015.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen (MeSH), Connaissances, attitudes et pratiques en santé (MeSH), Enquêtes et questionnaires (MeSH), Femelle (MeSH), Groupes de discussion (MeSH), Humains (MeSH), Motivation (MeSH), Mâle (MeSH), Pays-Bas (épidémiologie), Recherche qualitative (MeSH), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Vaccination (psychologie), Vaccins antigrippaux (usage thérapeutique), Vaccins antipneumococciques (usage thérapeutique).
- MESH :
- psychologie : Vaccination.
- usage thérapeutique : Vaccins antigrippaux, Vaccins antipneumococciques.
- épidémiologie : Pays-Bas.
- Adulte d'âge moyen, Connaissances, attitudes et pratiques en santé, Enquêtes et questionnaires, Femelle, Groupes de discussion, Humains, Motivation, Mâle, Recherche qualitative, Sujet âgé, Sujet âgé de 80 ans ou plus.
English descriptors
- KwdEn :
- Aged (MeSH), Aged, 80 and over (MeSH), Female (MeSH), Focus Groups (MeSH), Health Knowledge, Attitudes, Practice (MeSH), Humans (MeSH), Influenza Vaccines (therapeutic use), Male (MeSH), Middle Aged (MeSH), Motivation (MeSH), Netherlands (epidemiology), Pneumococcal Vaccines (therapeutic use), Qualitative Research (MeSH), Surveys and Questionnaires (MeSH), Vaccination (psychology).
- MESH :
- chemical , therapeutic use : Influenza Vaccines, Pneumococcal Vaccines.
- epidemiology : Netherlands.
- psychology : Vaccination.
- Aged, Aged, 80 and over, Female, Focus Groups, Health Knowledge, Attitudes, Practice, Humans, Male, Middle Aged, Motivation, Qualitative Research, Surveys and Questionnaires.
Abstract
BACKGROUND
Elderly in several European countries are currently being vaccinated against influenza and pneumococcal disease, and various reasons have been put forward to expand these programs. To successfully immunize the older adult population, however, it is crucial for the target group to accept such interventions. This study aims to elucidate the motives of Dutch persons aged ≥ 50 years for accepting vaccination.
METHODS
Thirteen focus groups were composed with persons aged 50 years and older. A semi-structured topic list with open-ended questions was used to guide the focus groups. The transcripts were analyzed according the principles of thematic survey. By an inductive process, the main themes and related subthemes were extracted from the responses.
RESULTS
Eight themes were found to play an important role in accepting vaccination: healthy aging; usefulness of vaccination in older age; risk of getting an infectious disease; vaccine characteristics; severity of the disease and its implications; the experiences of previous vaccinations; the influence of healthcare workers and other people; and the need for information.
CONCLUSIONS
This qualitative study reveals that acceptance of vaccination is not based on a single argument. The most important one appears to be the risk of getting an infectious disease. In that light, vaccination campaigns may emphasize the susceptibility of older adults. It is also advisable to consider the usefulness of vaccination in older age as an overall argument. A tailored approach to offering vaccination may be considered. Further research would be needed to determine the relative importance of the factors identified in this study.
DOI: 10.1186/s12889-015-1825-z
PubMed: 25981624
PubMed Central: PMC4446004
Links toward previous steps (curation, corpus...)
- to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000090
Links to Exploration step
pubmed:25981624Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Motives of Dutch persons aged 50 years and older to accept vaccination: a qualitative study.</title><author><name sortKey="Eilers, Renske" sort="Eilers, Renske" uniqKey="Eilers R" first="Renske" last="Eilers">Renske Eilers</name><affiliation wicri:level="1"><nlm:affiliation>University of Groningen, University Medical Center Groningen, Department of Epidemiology, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands. renske.eilers@rivm.nl.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>University of Groningen, University Medical Center Groningen, Department of Epidemiology, P.O. Box 30.001, 9700 RB, Groningen</wicri:regionArea></affiliation><affiliation wicri:level="1"><nlm:affiliation>Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, The Netherlands. renske.eilers@rivm.nl.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven</wicri:regionArea></affiliation></author><author><name sortKey="Krabbe, Paul F M" sort="Krabbe, Paul F M" uniqKey="Krabbe P" first="Paul F M" last="Krabbe">Paul F M. Krabbe</name><affiliation wicri:level="1"><nlm:affiliation>University of Groningen, University Medical Center Groningen, Department of Epidemiology, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands. p.f.m.krabbe@umcg.nl.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>University of Groningen, University Medical Center Groningen, Department of Epidemiology, P.O. Box 30.001, 9700 RB, Groningen</wicri:regionArea></affiliation></author><author><name sortKey="De Melker, Hester E" sort="De Melker, Hester E" uniqKey="De Melker H" first="Hester E" last="De Melker">Hester E. De Melker</name><affiliation wicri:level="1"><nlm:affiliation>Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, The Netherlands. hester.de.melker@rivm.nl.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25981624</idno><idno type="pmid">25981624</idno><idno type="doi">10.1186/s12889-015-1825-z</idno><idno type="pmc">PMC4446004</idno><idno type="wicri:Area/Main/Corpus">000090</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000090</idno><idno type="wicri:Area/Main/Curation">000090</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000090</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Motives of Dutch persons aged 50 years and older to accept vaccination: a qualitative study.</title><author><name sortKey="Eilers, Renske" sort="Eilers, Renske" uniqKey="Eilers R" first="Renske" last="Eilers">Renske Eilers</name><affiliation wicri:level="1"><nlm:affiliation>University of Groningen, University Medical Center Groningen, Department of Epidemiology, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands. renske.eilers@rivm.nl.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>University of Groningen, University Medical Center Groningen, Department of Epidemiology, P.O. Box 30.001, 9700 RB, Groningen</wicri:regionArea></affiliation><affiliation wicri:level="1"><nlm:affiliation>Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, The Netherlands. renske.eilers@rivm.nl.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven</wicri:regionArea></affiliation></author><author><name sortKey="Krabbe, Paul F M" sort="Krabbe, Paul F M" uniqKey="Krabbe P" first="Paul F M" last="Krabbe">Paul F M. Krabbe</name><affiliation wicri:level="1"><nlm:affiliation>University of Groningen, University Medical Center Groningen, Department of Epidemiology, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands. p.f.m.krabbe@umcg.nl.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>University of Groningen, University Medical Center Groningen, Department of Epidemiology, P.O. Box 30.001, 9700 RB, Groningen</wicri:regionArea></affiliation></author><author><name sortKey="De Melker, Hester E" sort="De Melker, Hester E" uniqKey="De Melker H" first="Hester E" last="De Melker">Hester E. De Melker</name><affiliation wicri:level="1"><nlm:affiliation>Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, The Netherlands. hester.de.melker@rivm.nl.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven</wicri:regionArea></affiliation></author></analytic><series><title level="j">BMC public health</title><idno type="eISSN">1471-2458</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term><term>Aged, 80 and over (MeSH)</term><term>Female (MeSH)</term><term>Focus Groups (MeSH)</term><term>Health Knowledge, Attitudes, Practice (MeSH)</term><term>Humans (MeSH)</term><term>Influenza Vaccines (therapeutic use)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Motivation (MeSH)</term><term>Netherlands (epidemiology)</term><term>Pneumococcal Vaccines (therapeutic use)</term><term>Qualitative Research (MeSH)</term><term>Surveys and Questionnaires (MeSH)</term><term>Vaccination (psychology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen (MeSH)</term><term>Connaissances, attitudes et pratiques en santé (MeSH)</term><term>Enquêtes et questionnaires (MeSH)</term><term>Femelle (MeSH)</term><term>Groupes de discussion (MeSH)</term><term>Humains (MeSH)</term><term>Motivation (MeSH)</term><term>Mâle (MeSH)</term><term>Pays-Bas (épidémiologie)</term><term>Recherche qualitative (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Sujet âgé de 80 ans ou plus (MeSH)</term><term>Vaccination (psychologie)</term><term>Vaccins antigrippaux (usage thérapeutique)</term><term>Vaccins antipneumococciques (usage thérapeutique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Influenza Vaccines</term><term>Pneumococcal Vaccines</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Netherlands</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Vaccins antigrippaux</term><term>Vaccins antipneumococciques</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Pays-Bas</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Female</term><term>Focus Groups</term><term>Health Knowledge, Attitudes, Practice</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Motivation</term><term>Qualitative Research</term><term>Surveys and Questionnaires</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Connaissances, attitudes et pratiques en santé</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Groupes de discussion</term><term>Humains</term><term>Motivation</term><term>Mâle</term><term>Recherche qualitative</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Elderly in several European countries are currently being vaccinated against influenza and pneumococcal disease, and various reasons have been put forward to expand these programs. To successfully immunize the older adult population, however, it is crucial for the target group to accept such interventions. This study aims to elucidate the motives of Dutch persons aged ≥ 50 years for accepting vaccination.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>Thirteen focus groups were composed with persons aged 50 years and older. A semi-structured topic list with open-ended questions was used to guide the focus groups. The transcripts were analyzed according the principles of thematic survey. By an inductive process, the main themes and related subthemes were extracted from the responses.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Eight themes were found to play an important role in accepting vaccination: healthy aging; usefulness of vaccination in older age; risk of getting an infectious disease; vaccine characteristics; severity of the disease and its implications; the experiences of previous vaccinations; the influence of healthcare workers and other people; and the need for information.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>This qualitative study reveals that acceptance of vaccination is not based on a single argument. The most important one appears to be the risk of getting an infectious disease. In that light, vaccination campaigns may emphasize the susceptibility of older adults. It is also advisable to consider the usefulness of vaccination in older age as an overall argument. A tailored approach to offering vaccination may be considered. Further research would be needed to determine the relative importance of the factors identified in this study.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">25981624</PMID><DateCompleted><Year>2015</Year><Month>12</Month><Day>28</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2015</Year><Month>May</Month><Day>16</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Motives of Dutch persons aged 50 years and older to accept vaccination: a qualitative study.</ArticleTitle><Pagination><MedlinePgn>493</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-015-1825-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Elderly in several European countries are currently being vaccinated against influenza and pneumococcal disease, and various reasons have been put forward to expand these programs. To successfully immunize the older adult population, however, it is crucial for the target group to accept such interventions. This study aims to elucidate the motives of Dutch persons aged ≥ 50 years for accepting vaccination.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Thirteen focus groups were composed with persons aged 50 years and older. A semi-structured topic list with open-ended questions was used to guide the focus groups. The transcripts were analyzed according the principles of thematic survey. By an inductive process, the main themes and related subthemes were extracted from the responses.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eight themes were found to play an important role in accepting vaccination: healthy aging; usefulness of vaccination in older age; risk of getting an infectious disease; vaccine characteristics; severity of the disease and its implications; the experiences of previous vaccinations; the influence of healthcare workers and other people; and the need for information.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This qualitative study reveals that acceptance of vaccination is not based on a single argument. The most important one appears to be the risk of getting an infectious disease. In that light, vaccination campaigns may emphasize the susceptibility of older adults. It is also advisable to consider the usefulness of vaccination in older age as an overall argument. A tailored approach to offering vaccination may be considered. Further research would be needed to determine the relative importance of the factors identified in this study.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eilers</LastName><ForeName>Renske</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Groningen, University Medical Center Groningen, Department of Epidemiology, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands. renske.eilers@rivm.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, The Netherlands. renske.eilers@rivm.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krabbe</LastName><ForeName>Paul F M</ForeName><Initials>PF</Initials><AffiliationInfo><Affiliation>University of Groningen, University Medical Center Groningen, Department of Epidemiology, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands. p.f.m.krabbe@umcg.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Melker</LastName><ForeName>Hester E</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, The Netherlands. hester.de.melker@rivm.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>05</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022242">Pneumococcal Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017144" MajorTopicYN="N">Focus Groups</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="Y">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009042" MajorTopicYN="Y">Motivation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N">Netherlands</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022242" MajorTopicYN="N">Pneumococcal Vaccines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="Y">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>09</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>05</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25981624</ArticleId><ArticleId IdType="doi">10.1186/s12889-015-1825-z</ArticleId><ArticleId IdType="pii">10.1186/s12889-015-1825-z</ArticleId><ArticleId IdType="pmc">PMC4446004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Adv Nurs. 2010 Oct;66(10):2297-308</Citation><ArticleIdList><ArticleId IdType="pubmed">20722815</ArticleId></ArticleIdList></Reference><Reference><Citation>J Natl Med Assoc. 2006 Oct;98(10):1678-84</Citation><ArticleIdList><ArticleId IdType="pubmed">17052061</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Geriatr. 2013;13:32</Citation><ArticleIdList><ArticleId IdType="pubmed">23586926</ArticleId></ArticleIdList></Reference><Reference><Citation>Prev Med. 2014 Dec;69:224-34</Citation><ArticleIdList><ArticleId IdType="pubmed">25456809</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2004 May 7;22(15-16):1992-2005</Citation><ArticleIdList><ArticleId IdType="pubmed">15121312</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 2011 Dec;59(12):2201-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22092044</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2000 Jun;30(6):931-3</Citation><ArticleIdList><ArticleId IdType="pubmed">10880303</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Educ Res. 2003 Dec;18(6):743-53</Citation><ArticleIdList><ArticleId IdType="pubmed">14654506</ArticleId></ArticleIdList></Reference><Reference><Citation>Mech Ageing Dev. 2007 Jan;128(1):92-105</Citation><ArticleIdList><ArticleId IdType="pubmed">17116321</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Gen Pract. 2007 May;57(538):352-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17504584</ArticleId></ArticleIdList></Reference><Reference><Citation>N C Med J. 2004 Jul-Aug;65(4):194-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15481486</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippePaysBasV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000090 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 000090 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippePaysBasV1
|flux= Main
|étape= Curation
|type= RBID
|clé= pubmed:25981624
|texte= Motives of Dutch persons aged 50 years and older to accept vaccination: a qualitative study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:25981624" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \
| NlmPubMed2Wicri -a GrippePaysBasV1
| This area was generated with Dilib version V0.6.35. |  |